Experiment Shows Many Seniors Falling Prey to ‘Impostor Scams’
MONDAY, Sept. 25, 2023 (HealthDay News) — Many older adults are savvy about telephone scams, but a sizable minority remain vulnerable, a new study suggests.Researchers found that when they simulated a “government impersonation” scam — contacting sen…
Learn MoreMany Receiving Alpelisib for Metastatic Breast Cancer Have Hyperglycemia
MONDAY, Sept. 25, 2023 (HealthDay News) — For patients with metastatic breast cancer receiving the PI3K inhibitor alpelisib, hyperglycemia often occurs, with a median time to onset of 16 days, according to a study published online Sept. 25 in Cancer….
Learn MoreCardiac Rehab Barriers Vary Globally According to Region
MONDAY, Sept. 25, 2023 (HealthDay News) — Cardiac rehabilitation (CR) barriers vary globally according to region, according to a study published online Sept. 24 in the Canadian Journal of Cardiology.Gabriela Lima de Melo Ghisi, P.T., Ph.D., from the …
Learn MoreExercise Intervention Has Biological Effect in Lynch Syndrome
MONDAY, Sept. 25, 2023 (HealthDay News) — An exercise intervention has biological effects on the immune system among patients with Lynch syndrome (LS), according to a study published online Sept. 19 in Clinical Cancer Research.Nan Deng, from The Univ…
Learn MoreWaist-to-Hip Ratio Has Strongest Link With All-Cause Mortality
MONDAY, Sept. 25, 2023 (HealthDay News) — Waist-to-hip ratio (WHR) has a strong, consistent association with all-cause mortality, regardless of body mass index (BMI), according to a study published online Sept. 20 in JAMA Network Open.Irfan Khan, fro…
Learn MoreBenefit of ICD Attenuated in CKD Patients Receiving Cardiac Resynchronization
MONDAY, Sept. 25, 2023 (HealthDay News) — For patients with advanced chronic kidney disease (CKD) receiving cardiac resynchronization therapy (CRT), the benefit of an implantable cardioverter defibrillator (ICD) may be attenuated, according to a stud…
Learn MoreBreast Cancer Drug Could Trigger Dangerous High Blood Sugar
MONDAY, Sept. 25, 2023 (HealthDay News) — For certain patients with advanced breast cancer, a drug called Piqray (alpelisib) may extend survival. But new research confirms the medication often causes seriously high blood sugar levels.“This is a very …
Learn More